Committee for Melbourne Honors Executive Director

5 February

Ms Janine Kirk AM has resigned from her position as Executive Director of the Committee for Melbourne to take up a senior role leading Ernst & Young’s Government practice in Victoria.

Ms Kirk, the Executive Director of the Committee since July 1995, will commence her position as Partner at the professional services firm in March 2007.

“Although I am sorry to be leaving an organization about which I am passionate, it is time to take on a new challenge using the skills and experience I have developed at the Committee in delivering a broad range of projects for the benefit of the city and community of Melbourne,” Ms Kirk said.

Ms Kirk said she felt privileged to have had the opportunity to work with a wide range of committed individuals from Melbourne’s business community, universities, arts institutions, unions and community groups to achieve the many positive outcomes delivered by the Committee over the past 12 years.

Mr George Pappas, Chairman of the Committee for Melbourne, said the Committee was naturally disappointed to lose Janine’s commitment to Melbourne and her outstanding leadership skills but understood and supported her decision to take on the new role which offers her a unique opportunity to build on her talents and experience.

“Janine has assisted in the building of a strong platform to help carry the Committee forward, ensuring it is well placed to continue its unique role of bringing together business, community and government to work collaboratively to address major issues impacting on Melbourne and Victoria,” Mr Pappas said.

What's On

February

S M T W T F S
 
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 

veski fellows in the news

Feb 2020 | Peter MacCallum Cancer Centre

Prof Mark Dawson - Australia-First Winner of Global Haematology Award

Jan 2020 | Nature MucosalImmunology

#1 most read paper of 2019 - Prof Ben Marsland's Nature MucosalImmunology publication.

 

“The real benefit of increasing fabrication rates is the transition from prototyping, making one offs, to actually going into production.”

Assoc Prof Timothy Scott

Tweets from @veskiorg